Molecular You’s Post

Precision health is an approach that tailors not just medical treatments but your entire health plan to your unique characteristics. It goes beyond medicine, considering your lifestyle, environment, and social factors to promote overall well-being. Imagine a health plan designed just for you, incorporating genetic insights, behaviors, and environmental factors to prevent issues and enhance your overall health.   Ramsay Santé’s Innovation Hub recently participated EIT Health Scandinavia“Swedish-French Accelerator 2.0” at Vinnova in Stockholm, focused in delivering precision health for patients. We found a selection of promising start-ups Ablemind, Epigenica, FenoMark Diagnostics AB, MedBeat and MoovmentPro in the accelerator cohort. It will be interesting to follow their journeys in the 🇫🇷 French market in the near future.   We also had the opportunity to share how #RamsaySanté and our #livinglabs are driving innovation and the implementation of new digital healthcare services and solutions in France and the Nordics for our company.   #digitalhealthcare #digitaltherapeutics #precisionhealth

Dive deep into the intricacies of health mechanisms at the molecular level, powered by AI-driven blood testing! Join us on an extraordinary journey led by James R Kean, MBA, CEO of Molecular You, leading the charge with the first and only multi-biomarker analytics platform. Imagine a world where clinicians and ACOs receive decision support based on highly accurate predictive risk profiles in 26 health areas! Their cutting-edge, low-cost molecular AI-powered blood analytics platform, fueled by quantitative proteomics and metabolomics (800 biomarker assay), is a game-changer. This revolutionary technology provides precise predictive risk profiles for 26 health conditions, with more in development. Join the forefront of healthcare innovation and explore the limitless possibilities with Molecular You. https://lnkd.in/dNJC5Ris Uli K. Chettipally, MD., MPH., Suzy Engwall 🚀🏥, Lavinia Herbei, MD, MBA, Dominique Kim, MPH, Nila Rafiq, MD, MBA #startupshowcase #moleculardiagnostics #healthcareinnovation

🎉 Massive Bio recently attended the Targi Salmed meeting in Poland, a gathering renowned for bringing the latest market novelties from the medical industry to the forefront. This event was a rich ground for debates on the current challenges facing the healthcare sector and served as an excellent showcase for the most promising startups in the MedTech market. 🔎 We had the opportunity to delve into discussions about AI technology's role in the medical industry and its potential to transform patient care. Participating in SALMED allowed us to engage with peers and thought leaders, share our insights and gain a deeper understanding of the evolving landscape of healthcare technology. 🌟 Our team left inspired by the innovative solutions and the collective drive towards better healthcare outcomes. As Massive Bio, we're excited to contribute to this progress with our AI-driven approaches and personalized patient care strategies. Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu, Aslan Aslanağı, Mert Sarı, Marta Halke-Markiewicz #SALMED #HealthcareInnovation #Medtech #AITechnology #MassiveBio #Poland

Save the date📌

Exciting LinkedIn Update! 🌐 Had the privilege of chatting with Ari Tulla, Founder & CEO of Elo Health, a trailblazer in Medicine 2.0! 🚀 Ari's entrepreneurial journey and thought leadership in healthcare are truly mind-blowing. His vision for merging technology with patient-centric care is reshaping the future of medicine. 🌟 Elo Health's impact is undeniable, and Ari's insights have left me inspired about the transformative power of HealthTech. Here's to pioneers like Ari Tula who drive innovation in the Medicine 2.0 space! 👏 #HealthInnovation #Medicine20 #EloHealth #ThoughtLeadership 🚀

We’re excited to announce the launch of our new webinar series: 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗔𝗰𝘁𝗶𝗼𝗻: 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲. 💡 Join us as we showcase the transformative power of technologies developed at Cleveland Clinic. This series will delve into cutting-edge medical research and highlight pioneering inventors and their groundbreaking inventions. 🔍 𝗪𝗵𝗮𝘁 𝘁𝗼 𝗘𝘅𝗽𝗲𝗰𝘁: ●𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀: Discover the latest breakthroughs in therapeutics, medical devices, digital health, and diagnostics. ●𝗘𝘅𝗽𝗲𝗿𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Hear from industry leaders and have an opportunity to engage in an question & answer open forum. ●𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: See how these innovations are being applied to solve pressing healthcare challenges. 📅 𝗪𝗵𝗲𝗻: Sept. 9, Oct. 4, Nov. 11, Dec. 13 📍 𝗪𝗵𝗲𝗿𝗲: Online - Register and learn more: https://hubs.li/Q02LYxV20 Don’t miss out on this opportunity to gain valuable knowledge and connect with fellow professionals driving change in healthcare. Let’s revolutionize healthcare together! #HealthcareInnovation #WebinarSeries #ClevelandClinicInnovations #FutureOfHealthcare #InnovationInAction #RevolutionizingHealthcare

2 days at health.tech conference means 2 days full of great conversations with like-minded people and insightful talks about #innovation in healthcare!   Our Community Manager Lea Renz had the pleasure of attending the #HT24 in Munich and came away with a positive summary:   ✅ Catching up with familiar faces   It's great to see #4CAccelerator startups in person from time to time to discuss their latest progress, current needs and newly achieved milestones. Hope to see you again soon: Inzipio, SURAG Medical, OSORA Medical Fracture Analytics, BesserEsser, PerAGraft GmbH, and QuantiLight!   ✅ Making new contacts   The conference provided an optimal framework to connect with different stakeholders - from startups to investors to other service providers. We look forward to staying in touch with you: steptics, TechNurse, healiva®, Evoleen Invest AG, fluidmobile GmbH, xtendr, Sedivention GmbH, Scheurer Medtech & Healthcare Consulting, Nuuro, MediOwl, BugSense Diagnostics, KINFINITY Care, Tilia Health, GAM Medical DACH, Brightmind.AI, ExoSphere.   ✅ Discussing current industry topics   The keynotes and panel discussions provided great insights and topics for discussion. Here are some quotes from this year's speakers that also highlight our approach to holistic #businessmodel development that addresses all the different stakeholder requirements:   “Every patient deserves that the solution he uses is reliable and of high quality.” - Moritz Hartmann, Roche “The most important thing we always look at is the business model. So, how will you convince the one who is paying?” - Daniel Bahr, Allianz   “DiGA is a revenue model, but not a growth model – never!” - Farina Schurzfeld, AndRobin     Many thanks to the team behind the health.tech conference for organizing this valuable event! See you next year ✌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

It was fantastic to attend the Milken Institute Global Conference in LA this week! A clear highlight was the #MedTech Trends panel with experts from across the landscape sharing pragmatic and future focussed #insights. Conor Hale of Fierce Healthcare chaired a fascinating discussion with Kelvin A. Baggett, Patient Square Capital, Andrew Fish, Medical Device Innovation Consortium (MDIC), Nada (Osman) Hanafi, MedTech Color, Ryan Larkin, Abbott, and Michelle Tarver, MD, PhD of the FDA heading up devices and radiological health. 📈Key trends discussed covered the latest in Imaging, Connected health, miniaturisation of devices, leveraging data, Gen AI and machine learning in new innovations across a range of therapeutic areas including Chronic Diseases, Cardiovascular, and women’s health. 👤And across all of this, the experts highlighted the need for companies entering this space to have a true value proposition for point of care for patients and clinicians, as well as deep consideration for health economics and payer/access requirements.

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐓𝐞𝐜𝐡!🌟 Inspira Technologies, an Israeli startup revolutionizing life support, has unveiled remarkable advancements in its HYLA Blood Sensor! 🩸 💡 This innovative sensor, attached to life support tubes, continuously monitors blood oxygen and carbon dioxide pressures, providing precise insights into health disorders and patient well-being. 👏 What's truly groundbreaking? The HYLA achieves an impressive 95% accuracy compared to traditional blood gas analyzers, eliminating the need for invasive and intermittent blood tests. 🌐✨ 🔬 These results are propelling Inspira towards FDA approval, expected in the coming months! 🏥🚀 The HYLA, originally designed for INSPIRA ART, is making waves in healthcare with plans for a standalone variant in the works. 🌈 Join the healthcare revolution! Stay tuned for more updates on this game-changing technology. 🚀💊 Comment below if you're as excited as we are! 👇 https://lnkd.in/dBGt3v3r #HealthTechInnovation #InspiraTechnologies #HealthcareRevolution #MedicalAdvancements

The Healthcare Stage I Episode 9(1) I Introducing Pulsar Medtech's innovative bone growth stimulation device for fresh fractures treatment   🎙️  Join us for an enlightening conversation with Elad Yakobson, CEO of Pulsar Medtech, a cutting-edge Israeli startup aiming to revolutionize fracture treatment with their Bone Growth Stimulation devices. Discover how Pulsar Medtech's lightweight patches are enhancing patient comfort and compliance, addressing challenges with current devices and potentially improving clinical outcomes. With FDA approval on the horizon, Pulsar Medtech aims to tap into a $500 million market annually, with even larger prospects in treating fresh fractures. Learn about the safety and efficacy of their innovative device, backed by rigorous clinical studies, and their upcoming pivotal study in the US in 2024. For investors seeking opportunities in the MedTech sector, this podcast offers valuable insights into Pulsar Medtech's trajectory and growth potential. I would like to personally thank Google campus in Tel Aviv for hosting us and for their ongoing support in innovative Israeli life science companies. 🎧Podcast is available on “The Healthcare Stage” YouTube channel, Spotify and Apple podcast   #TheHealthcareStage #MedTech #HealthcareInnovation #BoneHealing #Bonegrowthstimulation #Fractures #orthopedicpatients #VC #Investment #Startup #PulsarMedtech https://lnkd.in/d_H4nrrt